# PLAG1

## Overview
PLAG1 (Pleomorphic Adenoma Gene 1) is a gene that encodes a zinc finger transcription factor, known as the PLAG1 protein, which plays a pivotal role in the regulation of gene expression. The PLAG1 protein is characterized by its seven C2H2-type zinc finger domains, which facilitate its binding to specific DNA sequences, thereby modulating the transcription of target genes. This protein is primarily involved in the regulation of growth factors, such as insulin-like growth factor 2 (IGF2), which are crucial for normal embryonic development and cell proliferation. The activity of PLAG1 is intricately regulated by post-translational modifications, including sumoylation and acetylation, which influence its transcriptional activity and subnuclear localization. Aberrations in PLAG1 expression and function have been implicated in various human tumors, highlighting its significance as a potential diagnostic marker and therapeutic target (Zheng2005Sumoylation; Juma2015Emerging; Van2007PLAG1).

## Structure
The PLAG1 protein is characterized by its structure, which includes seven C2H2-type zinc finger domains located in the NH2-terminal half of the protein. These zinc fingers are crucial for DNA binding and possibly nuclear targeting, with fingers 6 and 7 interacting with the core DNA sequence and finger 3 recognizing a G-cluster (Zheng2005Sumoylation; Van2007PLAG1). The COOH-terminus of PLAG1 is serine-rich and functions as a transcriptional activation domain, essential for its role as a transcription factor (Van2007PLAG1; Kas1998Transcriptional).

PLAG1 undergoes several post-translational modifications, including SUMOylation, acetylation, and phosphorylation, which regulate its transcriptional activity. SUMOylation occurs in a conserved repression domain and inhibits transactivation, while acetylation activates the protein (Zheng2005Sumoylation; Van2007PLAG1). The protein's nuclear localization is facilitated by the zinc finger domains and a nuclear localization signal (KRKR) in the NH2-terminal region (Van2007PLAG1).

Alternative splicing of PLAG1 can result in a truncated isoform of 47 kDa due to the loss of exon 4, compared to the major transcript of 7.3 kb and a deduced molecular weight of 56 kDa (Van2007PLAG1).

## Function
PLAG1 (Pleomorphic Adenoma Gene 1) is a zinc finger transcription factor that plays a significant role in regulating gene expression in healthy human cells. It is primarily active in the nucleus, where it binds to specific DNA sequences to modulate the transcription of target genes. PLAG1 contains seven C2H2 zinc finger domains responsible for its DNA binding capacity, and it has a serine-rich region at the C-terminus that facilitates transcriptional activation (Juma2015Emerging; Van2007PLAG1).

In cell biology, PLAG1 is involved in the regulation of growth factors, such as insulin-like growth factor 2 (IGF2), which is crucial for normal embryonic development and cell proliferation. By binding to the regulatory elements of IGF2, PLAG1 stimulates its expression, thereby influencing growth and developmental processes (Juma2015Emerging; Van2007PLAG1). This regulation is essential for both embryonic development and normal physiological functions in various tissues (Juma2015Emerging).

PLAG1's activity is modulated by post-translational modifications, including sumoylation and acetylation, which affect its transcriptional activity and subnuclear localization. These modifications play a crucial role in balancing PLAG1's function in transcriptional complexes, impacting its role in cellular pathways (Zheng2005Sumoylation).

## Clinical Significance
The PLAG1 gene is implicated in various human tumors due to its role in chromosomal rearrangements and overexpression. In pleomorphic adenomas of the salivary glands, PLAG1 is frequently activated through chromosomal translocations, such as t(3;8)(p21;q12), leading to promoter swapping with genes like CTNNB1 and LIFR. This results in the overexpression of PLAG1, contributing to tumorigenesis (Voz1998The; Asp2006CHCHD7PLAG1). PLAG1 is also involved in lipoblastomas and hepatoblastomas, where it is highly expressed and associated with the activation of the IGF-II signaling pathway, which promotes cell proliferation (Van2007PLAG1).

In Wilms tumors, PLAG1 overexpression is linked to mutations in microRNA processing genes, leading to increased IGF2 expression and activation of the mTORC1 signaling pathway. This overexpression is associated with more aggressive tumor behavior and earlier relapse in patients (Chen2018Mutations). Additionally, PLAG1 is implicated in acute myeloid leukemia, where it is overexpressed in a subset of cases, potentially through an IGF2-independent pathway (Van2007PLAG1). These findings highlight the clinical significance of PLAG1 in various cancers, suggesting its potential as a diagnostic marker and therapeutic target.

## Interactions
PLAG1 is a transcription factor that interacts with various proteins and nucleic acids, playing a significant role in gene regulation. It binds to a specific bipartite consensus sequence in DNA, which is crucial for its function as a transcription factor (Abdollahi2006LOT1). PLAG1's activity is modulated by post-translational modifications, including sumoylation and acetylation. Sumoylation, facilitated by PIAS proteins, represses PLAG1's transactivation capacity, while acetylation by p300 enhances it (Van2007PLAG1; Zheng2005Sumoylation; Abdollahi2006LOT1).

PLAG1 also interacts with other proteins such as p53, influencing its transcriptional activity (Abdollahi2006LOT1). The protein's interaction with PIAS1, an E3 ligase, promotes its sumoylation, which is a reversible modification affecting PLAG1's stability and localization (Zheng2005Sumoylation). Additionally, PLAG1 is involved in the regulation of the IGF2 gene, where it acts as a promoter/enhancer facilitator, overcoming insulator functions in certain cellular contexts (AKHTAR2012Cell). These interactions and modifications highlight PLAG1's complex role in cellular processes and its potential oncogenic capacity.


## References


[1. (Zheng2005Sumoylation) Gang Zheng and Yu-Chung Yang. Sumoylation and acetylation play opposite roles in the transactivation of plag1 and plagl2*. Journal of Biological Chemistry, 280(49):40773–40781, December 2005. URL: http://dx.doi.org/10.1074/jbc.M504334200, doi:10.1074/jbc.m504334200. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M504334200)

[2. (Voz1998The) Marianne L Voz, Anna-Karin Åström, Koen Kas, Joachim Mark, Göran Stenman, and Wim JM Van de Ven. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of plag1 gene expression under control of the lifr promoter. Oncogene, 16(11):1409–1416, March 1998. URL: http://dx.doi.org/10.1038/sj.onc.1201660, doi:10.1038/sj.onc.1201660. This article has 126 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1201660)

[3. (Asp2006CHCHD7PLAG1) Julia Asp, Fredrik Persson, Maria Kost-Alimova, and Göran Stenman. Chchd7-plag1 andtcea1-plag1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas. Genes, Chromosomes and Cancer, 45(9):820–828, 2006. URL: http://dx.doi.org/10.1002/gcc.20346, doi:10.1002/gcc.20346. This article has 73 citations.](https://doi.org/10.1002/gcc.20346)

[4. (Kas1998Transcriptional) Koen Kas, Marianne L. Voz, Karen Hensen, Eva Meyen, and Wim J.M. Van de Ven. Transcriptional activation capacity of the novel plag family of zinc finger proteins. Journal of Biological Chemistry, 273(36):23026–23032, September 1998. URL: http://dx.doi.org/10.1074/jbc.273.36.23026, doi:10.1074/jbc.273.36.23026. This article has 117 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.36.23026)

[5. (Abdollahi2006LOT1) Abbas Abdollahi. Lot1 (zac1/plagl1) and its family members: mechanisms and functions. Journal of Cellular Physiology, 210(1):16–25, October 2006. URL: http://dx.doi.org/10.1002/jcp.20835, doi:10.1002/jcp.20835. This article has 80 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.20835)

[6. (AKHTAR2012Cell) MONIRA AKHTAR, CLAES HOLMGREN, ANITA GÖNDÖR, MATTIAS VESTERLUND, CHANDRASEKHAR KANDURI, CATHARINA LARSSON, and TOMAS J. EKSTRÖM. Cell type and context-specific function of plag1 for igf2 p3 promoter activity. International Journal of Oncology, 41(6):1959–1966, September 2012. URL: http://dx.doi.org/10.3892/ijo.2012.1641, doi:10.3892/ijo.2012.1641. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2012.1641)

[7. (Juma2015Emerging) Almas R Juma, Pauliina E Damdimopoulou, Sylvia V H Grommen, Wim J M Van de Ven, and Bert De Groef. Emerging role of plag1 as a regulator of growth and reproduction. Journal of Endocrinology, 228(2):R45–R56, November 2015. URL: http://dx.doi.org/10.1530/joe-15-0449, doi:10.1530/joe-15-0449. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.1530/joe-15-0449)

[8. (Van2007PLAG1) Frederik Van Dyck, Jeroen Declercq, Caroline Braem, and Wim Van de Ven. Plag1, the prototype of the plag gene family: versatility in tumour development (review). International Journal of Oncology, April 2007. URL: http://dx.doi.org/10.3892/ijo.30.4.765, doi:10.3892/ijo.30.4.765. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.30.4.765)

[9. (Chen2018Mutations) Kenneth S. Chen, Emily K. Stroup, Albert Budhipramono, Dinesh Rakheja, Diana Nichols-Vinueza, Lin Xu, Sarai H. Stuart, Abhay A. Shukla, Claudette Fraire, Joshua T. Mendell, and James F. Amatruda. Mutations in microrna processing genes in wilms tumors derepress theigf2regulatorplag1. Genes &amp; Development, 32(15–16):996–1007, July 2018. URL: http://dx.doi.org/10.1101/gad.313783.118, doi:10.1101/gad.313783.118. This article has 33 citations.](https://doi.org/10.1101/gad.313783.118)